Stem Cell Therapeutics Corp. Announces First Quarter 2009 Financial Results
CALGARY, ALBERTA–(Marketwire – May 27, 2009) – Stem Cell Therapeutics Corp. (”SCT”) (TSX VENTURE:SSS) today announced its financial results for the period ended March 31, 2009. Highlights from the first quarter of 2009 and up to May 27, 2009 – Detailed and cooperative work with the FDA resulted in the lift of the clinical hold on the Phase IIb clinical stroke trial, as announced on May 14, 2009 …
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Third Quarter Financial Results
Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial
Stem Cell Therapeutics Corp. Releases Encouraging Clinical Results and Provides Corporate Update